Semaglutide GLP-1 mimics the effects of GLP-1, which leads to decreased appetite, slower digestion, and increased feelings of fullness
Gao, X., et al., Efficacy and safety of semaglutide on weight loss in obese or overweight patients without diabetes: A systematic review and meta-analysis of randomized controlled trials
A great deal of research has shown that people with overweight or obesity have increased risk of premature death from various causes
Novo Nordisks Step-Up trial, based on clinical weight management, showed obese women taking semaglutide during menopause not only lost weight, they reduced their waist size and had less visceral fat, cutting the risk of heart attack and stroke
People who think they are getting enough protein are frequently hitting only 40 to 60 grams daily, which is well below the threshold for muscle preservation during active weight loss